"Établissement à taille humaine, en centre-ville, Pôle de référence, avec plus de 800 lits et places, le Centre Hospitalier d’Aurillac propose une offre de soins multidisciplinaire, polyvalente et de qualité. Avec 1800 employés dont 150 médecins, il assure une mission de service public de soins, conjuguant offre de proximité et niveau de technicité reconnu. Le Centre Hospitalier compte de nombreuses consultations spécialisées et un plateau technique performant : 2 IRM, 1 scanner, 1 plateau de coronarographie, un laboratoire central d’analyses médicales, 1 héliSMUR au sein d’une infrastructure de qualité. Il est l’établissement support du Groupement Hospitalier de Territoire Cantal."

During the past decade, CH Henri Mondor conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Henri Mondor" #1 sponsor was "University Hospital, Clermont-Ferrand" with 4 trials, followed by "BioMérieux" with 1 trials sponsored, "Biotronik France" with 1 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored and "Centre Hospitalier Emile Roux" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Henri Mondor" #1 collaborator was "AUDIPOG" with 1 trials as a collaborator, "Agence Régional de Santé du Centre" with 1 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator, "CH d'Aurillac" with 1 trials as a collaborator and "CH d'Issoire" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "CH Henri Mondor" are "Angioplasty" (1 trials), "Atrial Fibrillation" (1 trials), "Atrial Flutter" (1 trials), "Atrial Tachycardia" (1 trials) and "Blood Coagulation Factor Deficiencies" (1 trials). Many other conditions were trialed in "CH Henri Mondor" in a lesser frequency.

Most popular intervention types in "CH Henri Mondor" are "Other" (5 trials), "Procedure" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Administering diagnosis orientation questionnaires for the screening of possible sleep disorders" (1 trials), "Covid ICU containment measures" (1 trials), "Data collection" (1 trials), "MRI" (1 trials) and "Sensura Mio Bodyfit technology ostomy pouches" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Henri Mondor" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CH Henri Mondor". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in CH Henri Mondor, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH Henri Mondor, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".